Cardiff Oncology Inc (NASDAQ: CRDF)

Business

Cardiff Oncology Inc (NASDAQ:CRDF) gain 6.17% – Is It right time to buy?

Noah Smith

Cardiff Oncology Inc (CRDF) saw an uptrend of 6.17% in the recent trading with $2.41 being its most recent. The ...

Value Stocks

Cardiff Oncology Inc (NASDAQ:CRDF) gain 1.82% – Is It right time to buy?

Colin Adrian

Cardiff Oncology Inc (CRDF) saw an uptrend of 1.82% in the recent trading with $2.24 being its most recent. The ...

Baxter Report
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.